Impairment of absorption of digoxin by acarbose

被引:13
作者
Miura, T
Ueno, K
Tanaka, K
Sugiura, Y
Mizutani, M
Takatsu, F
Takano, Y
Shibakawa, M
机构
[1] Natl Cardiovasc Ctr, Dept Pharm, Suita, Osaka 5658565, Japan
[2] Kousei Hosp, Dept Pharm Serv, Aichi, Japan
[3] Kousei Hosp, Dept Internal Med, Div Cardiol, Aichi, Japan
关键词
D O I
10.1002/j.1552-4604.1998.tb04474.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study was conducted to determine the effect of acarbose on serum concentrations of digoxin in healthy male volunteers. A randomized crossover design with three phases was used. In phase 1 participants received 0.5 mg of digoxin alone. In phase 2 they received 0.5 mg of digoxin 0.5 hours after a 200-mg dose of acarbose. In phase 3 they received 100 mg of acarbose 0.5 hours before each meal three times daily for 3 days. On the fourth day, they received 0.5 mg of digoxin 0.5 hours after a 100-mg dose of acarbose. Area under the concentration-time curve (AUC(0-48)) and mean maximum concentration (C-max) were significantly lower and t(max) significantly increased in phases 2 and 3 compared with phase 1. These results indicate that the absorption of digoxin is reduced by administration of acarbose, and that one of the major mechanisms of this interaction may be due to the pharmacodynamics of acarbose. Journal of Clinical Pharmacology, 1998;38:654-657 (C)1998 The American College of Clinical Pharmacology.
引用
收藏
页码:654 / 657
页数:4
相关论文
共 14 条
[1]   CLINICAL PHARMACOKINETICS OF DIGOXIN 1980 [J].
ARONSON, JK .
CLINICAL PHARMACOKINETICS, 1980, 5 (02) :137-149
[2]   DECREASED BIOAVAILABILITY OF DIGOXIN DUE TO ANTACIDS AND KAOLIN-PECTIN [J].
BROWN, DD ;
JUHL, RP .
NEW ENGLAND JOURNAL OF MEDICINE, 1976, 295 (19) :1034-1037
[3]   EFFECTIVENESS OF ACARBOSE, AN ALPHA-GLUCOSIDASE INHIBITOR, IN UNCONTROLLED NON-OBESE NON-INSULIN DEPENDENT DIABETES [J].
BUCHANAN, DR ;
COLLIER, A ;
RODRIGUES, E ;
MILLAR, AM ;
GRAY, RS ;
CLARKE, BF .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 34 (01) :51-53
[4]  
CALDWELL JH, 1976, CLIN PHARMACOL THER, V19, P410
[5]  
DIMITRIADIS G, 1992, HORM METAB RES, V26, P42
[6]   QUINIDINE-DIGOXIN INTERACTION - PHARMACOKINETICS, UNDERLYING MECHANISM AND CLINICAL IMPLICATIONS [J].
DOERING, W .
NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (08) :400-404
[7]  
HARGER WD, 1979, NEW ENGL J MED, V300, P1238
[8]   THE INFLUENCE OF VERAPAMIL ON SERUM DIGOXIN CONCENTRATION [J].
KLEIN, HO ;
LANG, R ;
WEISS, E ;
DISEGNI, E ;
LIBHABER, C ;
GUERRERO, J ;
KAPLINSKY, E .
CIRCULATION, 1982, 65 (05) :998-1003
[9]  
MANNINEN V, 1973, LANCET, V1, P398
[10]  
MATIVIER B, 1984, INT J NUCL MED BIOL, V11, P103